Prognosis
Escalating AstraZeneca Spat Highlights EU Vaccine Fiasco
- Germany seeks limits on vaccine exports, citing U.S. measures
- AstraZeneca under pressure as EU struggles with pandemic
This article is for subscribers only.
The European Union’s standoff with AstraZeneca Plc over delayed vaccine deliveries widened, with Germany taking aim at U.S. export restrictions and signaling its backing for similar curbs.
German Chancellor Angela Merkel hinted at potential retaliation against the U.S. after her government called for a limit on exports of vaccines out of the bloc, adding to signs of ever more brutal competition for the life-saving shots.